Excess mortality of schizophrenia: A meta-analysis

Cited by (869)

Items 101–200 of 869

1. Suicide in schizophrenia
   Andreas Carlborg, Kajsa Winnerbäck, Erik Gunnar Jönsson, Jussi Jokinen, Peter Nordström · 2010 · Expert Review of Neurotherapeutics
2. Increased mortality in depressive disorders: A review
   Pim J. Cuijpers, Robert A. Schoevers · 2004 · Current Psychiatry Reports
3. Potential mechanisms of atypical antipsychotic-induced metabolic derangement: Clues for understanding obesity and novel drug design
   Roberto Coccurello, Anna Moles · 2010 · Pharmacology & Therapeutics
4. World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia Part 3: Update 2015 Management of special circumstances: Depression, Suicidality, substance use disorders and pregnancy and lactation
   Alkomiet Hasan, Peter Falkai, Thomas Wobrock, Jeffrey Alan Lieberman, Birte Yding Glenthoj, Wagner F. Gattaz, Florence Thibaut, Hans‐Jürgen Möller, on behalf of the WFSBP Task Force on Treatment Guidelines for Schizophrenia · 2015 · The World Journal of Biological Psychiatry
5. Mental health service provision in low and middle-income countries
   Stefan Weinmann, Markus Koesters · 2016 · Current Opinion in Psychiatry
6. Disparities in Unmet Need for Mental Health Services in the United States, 1997–2010
   John M. Roll, Jae J. Kennedy, Melanie Tran, Donelle N. Howell · 2013 · Psychiatric Services
7. High prevalence of the metabolic syndrome among a Swedish cohort of patients with schizophrenia
   Staffan Hägg, Yvonne Lindblom, Tom Mjörndal, Rolf Adolfsson · 2006 · International Clinical Psychopharmacology
8. Assessing QT Interval Prolongation and its Associated Risks with Antipsychotics
   Jimmi Nielsen, Claus Graff, Jørgen Kim Kanters, Egon Steen Toft, David M. Taylor, Jonathan M. Meyer · 2011 · CNS Drugs
9. Side Effects of Atypical Antipsychotics: Extrapyramidal Symptoms and the Metabolic Syndrome
   Arshia A. Shirzadi, S. Nassir Ghaemi · 2006 · Harvard Review of Psychiatry
10. A cohort study on mental disorders, stage of cancer at diagnosis and subsequent survival
    Chin‐Kuo Chang, Richard D. Hayes, Matthew T.M. Broadbent, Matthew H. Hotopf, Elizabeth Davies, Henrik Møller, Robert J. Stewart · 2014 · BMJ Open
11. Characteristics of primary care visits for individuals with severe mental illness in a national sample
    Gail L. Daumit, Laura A. Pratt, Rosa M. Crum, Neil R. Powe, Daniel E. Ford · 2002 · General Hospital Psychiatry
12. Cause-specific life years lost among persons diagnosed with schizophrenia: Is it getting better or worse?
    Thomas Munk Laursen, Oleguer Plana‐Ripoll, Per Kragh Andersen, John Joseph McGrath, Anita Toender, Merete Nordentoft, Vladimir Canudas‐Romo, Annette Erlangsen · 2018 · Schizophrenia Research
13. Considering a frame of reference for physical activity research related to the cardiometabolic risk profile in schizophrenia
    Davy Vancampfort, Jan Knapen, Michel Probst, Ruud van Winkel, Seppe Deckx, Katrien Maurissen, Joseph Peuskens, Marc D. Binder · 2010 · Psychiatry Research
14. Pharmacological Treatments for First-Episode Schizophrenia
    Delbert G. Robinson · 2005 · Schizophrenia Bulletin
15. Toxoplasma gondii antibody titers and history of suicide attempts in patients with schizophrenia
    Olaoluwa O. Okusaga, PATRICIA W. LANGENBERG, Aamar Sleemi, Dipika Vaswani, Ina Giegling, Annette M. Hartmann, Bettina Konte, Marion Friedl, Maureen E. Groer, Robert H. Yolken et al. · 2011 · Schizophrenia Research
16. Initial medical work‐up of first‐episode psychosis: a conceptual review
    Oliver Freudenreich, S. Charles Schulz, DONALD C. GOFF · 2009 · Early Intervention in Psychiatry
17. Temporal trends in associations between severe mental illness and risk of cardiovascular disease: A systematic review and meta-analysis
    Amanda Lambert, Helen M. Parretti, Emma Pearce, Malcolm James Price, Mark Robert Riley, Ronan P. Ryan, Natalie Tyldesley‐Marshall, Tuba Saygın Avşar, Gemma Matthewman, Alexandra Lee et al. · 2022 · PLoS Medicine
18. Antipsychotic Polypharmacy and Risk of Death From Natural Causes in Patients With Schizophrenia
    Lone Baandrup, Christiane Gasse, Vibeke D. Jensen, Birte Yding Glenthoj, Merete Nordentoft, Henrik Lublin, Anders Fink‐Jensen, Anne Lindhardt, Preben Bo Mortensen · 2009 · The Journal of Clinical Psychiatry
19. Metabolic risk during antipsychotic treatment
    John W. Newcomer · 2004 · Clinical Therapeutics
20. State anxiety, psychological stress and positive well-being responses to yoga and aerobic exercise in people with schizophrenia: a pilot study
    Vancampfort, Davy, De Hert, Marc, Knapen, Jan, Wampers, Martien, Demunter, Hella, Deckx, Seppe, Maurissen, Katrien, Probst, Michel · 2011 · Disability and Rehabilitation
21. A widening longevity gap between people with schizophrenia and general population: A literature review and call for action
    Ellen Lee, Jinyuan Liu, Xin Ming Tu, Barton W. Palmer, Lisa T. Eyler, Dilip V. Jeste · 2017 · Schizophrenia Research
22. Antipsychotic-Induced Venous Thromboembolism
    Staffan Hägg, Olav Spigset · 2002 · CNS Drugs
23. Comparative Mortality Associated With Ziprasidone and Olanzapine in Real-World Use Among 18,154 Patients With Schizophrenia: The Ziprasidone Observational Study of Cardiac Outcomes (ZODIAC)
    Strom, Brian L., Eng, Sybil M., Faich, Gerald, Reynolds, Robert F., D'Agostino, Ralph B., Ruskin, Jeremy, Kane, John M. · 2011 · American Journal of Psychiatry
24. Sleep Disturbances and Suicide Risk in an 8-Year Longitudinal Study of Schizophrenia-Spectrum Disorders
    Shirley Xin Li, Siu Ping Lam, Jihui Zhang, Mandy Wai Man Yu, Joey Wing Yan Chan, Cassandra Sheung Yan Chan, Colin Alexander Espie, Daniel H. Freeman, Oliver John Mason, Yun Kwok Wing · 2016 · SLEEP
25. Course and Outcome of Schizophrenia
    Heinz Häfner, W. an der Heiden · 2003 · Wiley eBooks
26. Melatonin attenuates antipsychotic metabolic effects: an eight‐week randomized, double‐blind, parallel‐group, placebo‐controlled clinical trial
    Francisco Romo‐Nava, Dení Álvarez-Icaza, Ana Fresán, Ricardo Arturo Saracco-Álvarez, Claudia Becerra‐Palars, Julia Moreno, Martha Patricia Ontiveros Uribe, Carlos Berlanga, Gerhard Heinze, Ruud M. Buijs · 2014 · Bipolar Disorders
27. Metabolic disease and cardiovascular risk in people treated with antipsychotics in the community
    Paul Mackin, David Timothy Bishop, Helen Watkinson, Peter Gallagher, Ian Nicol Ferrier · 2007 · The British Journal of Psychiatry
28. Lifestyle and physical health in schizophrenia
    Moira Connolly, Ciara Kelly · 2005 · Advances in Psychiatric Treatment
29. Testing the hypothesis of accelerated cerebral white matter aging in schizophrenia and major depression
    Kochunov, Peter, Glahn, David C., Rowland, Laura M., Olvera, Rene L., Winkler, Anderson, Yang, Yi-Hong, Sampath, Hemalatha, Carpenter, Will T., Duggirala, Ravindranath, Curran, Joanne et al. · 2013 · Biological Psychiatry
30. Risk for coronary heart disease in people with severe mental illness
    David Osborn, Irwin Nazareth, Michael King · 2006 · The British Journal of Psychiatry
31. Obesity, dyslipidaemias and smoking in an inpatient population treated with antipsychotic drugs
    Carol Paton, Radia Esop, Corina Young, David M. Taylor · 2004 · Acta Psychiatrica Scandinavica
32. Are the cardiometabolic complications of schizophrenia still neglected? Barriers to care
    Tim J R Lambert, John W. Newcomer · 2009 · The Medical Journal of Australia
33. Efficacy and safety of direct transition to risperidone long-acting injectable in patients treated with various antipsychotic therapies
    Hans-J rgen M ller, Pierre‐Michel Llorca, Emilio Sacchetti, Stephen D. Martin, Rossella Medori, Eduard Parellada · 2005 · International Clinical Psychopharmacology
34. Dyslipidemia Independent of Body Mass in Antipsychotic-Treated Patients Under Real-Life Conditions
    Astrid B. Birkenaes, Kåre I. Birkeland, John Abel Engh, Ann Færden, Halldóra Jónsdóttir, Petter Andreas Ringen, Svein Friis, Stein Opjordsmoen, Ole A. Andreassen · 2008 · Journal of Clinical Psychopharmacology
35. Ten-year prospective follow-up study of the mortality by suicide in schizophrenic patients
    Frédéric Limosin, J.-Y. Loze, Alain Philippe, F Casadebaig, F. Rouillon · 2007 · Schizophrenia Research
36. Metabolic disturbance in first-episode schizophrenia
    Jogin H. Thakore · 2004 · The British Journal of Psychiatry
37. Revascularisation and mortality rates following acute coronary syndromes in people with severe mental illness: comparative meta-analysis
    Alex J. Mitchell, David M. Lawrence · 2011 · The British Journal of Psychiatry
38. Healthy living interventions and schizophrenia: a systematic review
    Tim Bradshaw, Karina Lovell, Neil Harris · 2005 · Journal of Advanced Nursing
39. Prevalence of suicide attempts in individuals with schizophrenia: a meta-analysis of observational studies
    Li Lu, Min Dong, Ling Zhang, Xiao-Min Zhu, Gabor Sandor Ungvari, Chee H. Ng, Gang Wang, Yu‐Tao Xiang · 2019 · Epidemiology and Psychiatric Sciences
40. Schizophrenia: a purinergic hypothesis
    Diogo Rizzato Lara, Diogo Onofre Souza · 2000 · Medical Hypotheses
41. Effectiveness and cost-effectiveness of lifestyle interventions on physical activity and eating habits in persons with severe mental disorders: A systematic review
    Nick Verhaeghe, Jan De Maeseneer, Lea Maes, Cornelis Van Heeringen, Lieven Annemans · 2011 · International Journal of Behavioral Nutrition and Physical Activity
42. Predictors and outcome characteristics associated with suicidal behaviour in early psychosis: a two‐year follow‐up of first‐admitted subjects
    Hélène Verdoux, F. Liraud, B. Gonzales, F. Assens, F. Abalan, J. van Os · 2001 · Acta Psychiatrica Scandinavica
43. Risk factors for completed suicide in schizophrenia and other chronic psychotic disorders: A case–control study
    Alexander McGirr, Michel Tousignant, Danielle Routhier, Louise Pouliot, Nadia Chawky, Howard C. Margolese, Gustavo Turecki · 2006 · Schizophrenia Research
44. The evolutionary paradox and the missing heritability of schizophrenia
    Jenny van Dongen, Dorret Irene Boomsma · 2013 · American Journal of Medical Genetics Part B Neuropsychiatric Genetics
45. Randomized Comparison of Olanzapine Versus Risperidone for the Treatment of First-Episode Schizophrenia: 4-Month Outcomes
    Delbert G. Robinson, Margaret G. Woerner, Barbara A. Napolitano, Raman C. Patel, Serge M. Sevy, Handan Gunduz‐Bruce, Jose M Soto-Perello, Alan J. Mendelowitz, Ali Khadivi, Rachel Miller et al. · 2006 · American Journal of Psychiatry
46. Schizophrenia Spectrum Disorders in Later Life: Prevalence and Distribution of Age at Onset and Sex in a Dutch Catchment Area
    Paul David Meesters, Lieuwe de Haan, Hannie C. Comijs, Max L. Stek, Maureen M.J. Smeets-Janssen, Marjan R. Weeda, Piet Eikelenboom, Johannes H. Smit, Aartjan T.F. Beekman · 2010 · American Journal of Geriatric Psychiatry
47. Lifestyle factors and the metabolic syndrome in Schizophrenia: a cross-sectional study
    Adrian Hugh Heald, John Pendlebury, Simon George Anderson, Vinesh Narayan, Mark Guy, Martin Gibson, Peter Michael Haddad, Mark A. Livingston · 2017 · Annals of General Psychiatry
48. Schizophrenia: Metabolic aspects of aetiology, diagnosis and future treatment strategies
    Laura Wiseman Harris, Paul C. Guest, Matthew Thomas Wayland, Yagnesh Umrania, Divya Krishnamurthy, Hassan Rahmoune, Sabine Bahn · 2012 · Psychoneuroendocrinology
49. The brain-derived neurotrophic factor gene in suicidal behaviour: a meta-analysis
    Clement C.H. Zai, Mirko Manchia, Vincenzo De Luca, Arun Kumar Tiwari, Nabilah I. Chowdhury, Gwyneth C. Zai, Ryan P. Tong, Zeynep Yılmaz, Sajid Ali Shaikh, John Strauss et al. · 2011 · The International Journal of Neuropsychopharmacology
50. Association of an Early Intervention Service for Psychosis With Suicide Rate Among Patients With First-Episode Schizophrenia-Spectrum Disorders
    Chan, Sherry Kit Wa, Chan, Stephanie Wing Yan, Pang, Herbert H., Yan, Kang K., Hui, Christy Lai Ming, Chang, Wing Chung, Lee, Edwin Ho Ming, Chen, Eric Yu Hai · 2018 · JAMA Psychiatry
51. The heart of the matter: cardiometabolic care in youth with psychosis
    Jackie Curtis, Hannah D. Newall, Katherine Samaras · 2012 · Early Intervention in Psychiatry
52. Schizophrenia, Psychiatric Genetics, and Darwinian Psychiatry: An Evolutionary Framework
    Godfrey D. Pearlson, Bradley S. Folley · 2007 · Schizophrenia Bulletin
53. Atypical antipsychotics and metabolic syndrome in patients with schizophrenia: risk factors, monitoring, and healthcare implications.
    Henry Riordan, Paola Antonini, Michael F Murphy · 2011 · Europe PMC (PubMed Central)
54. Five-year mortality in a cohort of people with schizophrenia in Ethiopia
    Solomon Teferra, Teshome Shibre, Abebaw Fekadu, Girmay Medhin, Asfaw Wakwoya, Atalay Alem, Gunnar Kullgren, Lars H. Jacobsson · 2011 · BMC Psychiatry
55. Excess mortality in severe mental disorders: A systematic review and meta-regression
    Suhailah Ali, Damian Francesco Santomauro, Alize J Ferrari, Fiona Charlson · 2022 · Journal of Psychiatric Research
56. Stigma and discrimination against people with schizophrenia related to medical services
    Judit Harangozó, Blanca Reneses, Elaine Brohan, Julia Sebes, Gábor Csukly, JJ López-Ibor, Norman Sartorius, Diana Susan Rose, Graham Thornicroft · 2013 · International Journal of Social Psychiatry
57. Packages of Care for Schizophrenia in Low- and Middle-Income Countries
    Mari, Jair de Jesus, Razzouk, Denise, Thara, Rangaswamy, Eaton, Julian, Thornicroft, Graham · 2009 · PLoS Medicine
58. Abnormalities in chemokine levels in schizophrenia and their clinical correlates
    Suzi Hong, Ellen Lee, Averria Sirkin Martin, Benchawanna Soontornniyomkij, Virawudh Soontornniyomkij, Cristian L. Achim, Chase Reuter, Michael R. Irwin, Lisa T. Eyler, Dilip V. Jeste · 2016 · Schizophrenia Research
59. Cardiovascular Disease Mortality in Patients With Chronic Schizophrenia Treated With Clozapine
    Deanna L. Kelly, Robert P. McMahon, Fang Liu, Raymond C. Love, Heidi J. Wehring, Joo-Cheol Shim, Kimberly R. Warren, Robert R. Conley · 2010 · The Journal of Clinical Psychiatry
60. Metabolic Syndrome in Schizophrenia
    Nidhi Malhotra, Sandeep Grover, Subho Chakrabarti, Parmanand Kulhara · 2013 · Indian Journal of Psychological Medicine
61. Metabolic syndrome in drug-naïve and drug-free patients with schizophrenia and in their siblings
    Aslı Enez Darçın, Serçin Yalçın Çavuş, Nesrin Dılbaz, Hasan Kaya, Eylem Dogan · 2015 · Schizophrenia Research
62. Health behavior in psychiatric in‐patients compared with a German general population sample
    Reinhold Kilian, Thomas M Becker, K. Krüger, S. Schmid, Karel Frasch · 2006 · Acta Psychiatrica Scandinavica
63. A prospective study of monitoring practices for metabolic disease in antipsychotic-treated community psychiatric patients
    Paul Mackin, David R. Bishop, Helen Watkinson · 2007 · BMC Psychiatry
64. Placing physical activity in mental health care: A leadership role for mental health nurses
    Brenda Happell, Chris Platania‐Phung, David S. Scott · 2011 · International Journal of Mental Health Nursing
65. Evolving role of mental health nurses in the physical health care of people with serious mental health illness
    Tim Bradshaw, Rebecca Pedley · 2012 · International Journal of Mental Health Nursing
66. The impact of mental illness on cardiac outcomes: A review for the cardiologist
    Gillian L. Sowden, Jeff C. Huffman · 2008 · International Journal of Cardiology
67. Subjective experience and suicidal ideation in schizophrenia
    Borut Škodlar, Martina Žmuc Tomori, Josef Parnas · 2008 · Comprehensive Psychiatry
68. Suicide in schizophrenia: findings from a national clinical survey
    HUNT, ISABELLE M., KAPUR, NAV, WINDFUHR, KIRSTEN, ROBINSON, JO, BICKLEY, HARRIET, FLYNN, SANDRA, PARSONS, REBECCA, BURNS, JAMES, SHAW, JENNY, APPLEBY, LOUIS · 2006 · Journal of Psychiatric Practice
69. Patterns of primary care and mortality among patients with schizophrenia or diabetes: a cluster analysis approach to the retrospective study of healthcare utilization
    Laurel Anne Copeland, John E. Zeber, Chen Pin Wang, Michael Leo Parchman, Valerie A. Lawrence, Marcia M. Valenstein, Alexander L. Miller · 2009 · BMC Health Services Research
70. Association of Psychiatric Illness and All-Cause Mortality in the National Department of Veterans Affairs Health Care System
    Lydia Chwastiak, Robert Alan Rosenheck, Rani A. Desai, Lewis E. Kazis · 2010 · Psychosomatic Medicine
71. The Early Psychosis Intervention Center (EPICENTER): development and six-month outcomes of an American first-episode psychosis clinical service
    Nicholas J. K. Breitborde, Emily K. Bell, David Dawley, Cindy B. Woolverton, Alan E. Ceaser, Allison C. Waters, Spencer C. Dawson, Andrew W. Bismark, Angelina J. Polsinelli, Lisa A. Bartolomeo et al. · 2015 · BMC Psychiatry
72. Schizophrenia patients at higher risk of diabetes, hypertension and hyperlipidemia: A population-based study
    Chun-Hui Liao, Chen-Shu Chang, Wan-Ching Wei, Shih‐Ni Chang, Chien‐Chang Liao, Hsien‐Yuan Lane, Fung-Chang Sung · 2011 · Schizophrenia Research
73. Effects of aerobic interval training on metabolic complications and cardiorespiratory fitness in young adults with psychotic disorders: A pilot study
    Amal Abdel‐Baki, Véronique Brazzini-Poisson, Francis Marois, Elaine D. Letendre, Antony D. Karelis · 2013 · Schizophrenia Research
74. Course and Outcome
    W. an der Heiden, Heinz Häfner · 2010 · Wiley eBooks
75. Case Managers' Attitudes to the Physical Health of Their Patients
    Brendan Hyland, Fiona K. Judd, Sandra K. Davidson, Damien Jolley, Barbara M Hocking · 2003 · Australian & New Zealand Journal of Psychiatry
76. Suicidality and substance misuse in first-admitted subjects with psychotic disorder
    Hélène Verdoux, F. Liraud, B. Gonzalès, François Assens, F. Abalan, Jim van Os · 2007 · Acta Psychiatrica Scandinavica
77. Widespread covariation of early environmental exposures and trait-associated polygenic variation
    Eva M. L. Krapohl, Laurie J. Hannigan, Jean‐Baptiste Pingault, Hamel Patel, Neli Kadeva, Charles J. C. Curtis, Gerome D. Breen, Stephen Newhouse, Thalia Catherine Eley, Paul F. O’Reilly et al. · 2017 · Proceedings of the National Academy of Sciences
78. Cardiovascular disease risk factors in relation to suicide mortality in Asia: prospective cohort study of over one million Korean men and women
    Sun Ha Jee, Mika Kivimaki B, Hee‐Cheol Kang, I. S. Park, Jonathan M. Samet, George David Batty · 2011 · European Heart Journal
79. A continuum of premature death. Meta-analysis of competing mortality in the psychosocially vulnerable
    Neeleman, J · 2001 · International Journal of Epidemiology
80. Modeling synaptogenesis in schizophrenia and autism using human iPSC derived neurons
    Christa Whelan Habela, Hongjun Song, Guo‐li Ming · 2015 · Molecular and Cellular Neuroscience
81. Gut microbiome in serious mental illnesses: A systematic review and critical evaluation
    Tanya T. Nguyen, Hugh Hathaway, Tomasz Kościółek, Rob D. Knight, Dilip V. Jeste · 2019 · Schizophrenia Research
82. Increased Risk of Nursing Home Admission Among Middle Aged and Older Adults With Schizophrenia
    Alice O. Andrews, Stephen J. Bartels, Haiyi Xie, William J. Peacock · 2009 · American Journal of Geriatric Psychiatry
83. Health Care for Patients with Serious Mental Illness: Family Medicine's Role
    Nancy E. Morden, Lisa A. Mistler, William Brinson Weeks, Stephen J. Bartels · 2009 · The Journal of the American Board of Family Medicine
84. New directions in the epidemiology of schizophrenia
    John Joseph McGrath, Ezra Susser · 2009 · The Medical Journal of Australia
85. Physical illness and lifestyle risk factors in people with their first presentation of psychosis
    Chiara Samele, Maxine X. Patel, Jane E. Boydell, Morven Leese, Simon C. Wessely, Robin M. Murray · 2006 · Social Psychiatry and Psychiatric Epidemiology
86. The association between schizophrenia and cigarette smoking: A review of the literature and implications for mental health nursing practice
    Andrea McCloughen · 2003 · International Journal of Mental Health Nursing
87. Markers of thrombogenesis are activated in unmedicated patients with acute psychosis: a matched case control study
    Jiří Masopust, Radován Malý, Ctirad Andrýs, Martin Vališ, Jan Bažant, Ladislav Hosák · 2011 · BMC Psychiatry
88. Early intervention in psychosis: From clinical intervention to health system implementation
    Cláudio Csillag, Merete Nordentoft, Masafumi Mizuno, David McDaid, Celso Arango, Jo Smith, Antonio Lora, Swapna Kamal Verma, Teresa Di Fiandra, Peter Brian Jones · 2017 · Early Intervention in Psychiatry
89. Excess mortality among long-stay psychiatric patients in Northern Finland
    Sami Räsänen, Helinä H Hakko, Kaisa M. Viilo, Victor Benno Meyer‐Rochow, Juha Moring · 2003 · Social Psychiatry and Psychiatric Epidemiology
90. Mortality in people with schizophrenia in rural China
    Mao‐Sheng Ran, Eric Yu Hai Chen, Yeates Conwell, Clw Chan, PAUL S. F. YIP, Meng‐Ze Xiang, Eric D. Caine · 2007 · The British Journal of Psychiatry
91. [Consensus on physical health of patients with schizophrenia from the Spanish Societies of Psychiatry and Biological Psychiatry].
    Jerónimo Sáiz Ruiz, J Bobes García, J Vallejo Ruiloba, José Giner Ubago, M P García-Portilla González · 2008 · Actas Españolas de Psiquiatría
92. The paradox of premature mortality in schizophrenia: new research questions
    Hiram Joseph Wildgust, Richard Eric Hodgson, Mike Beary · 2010 · Journal of Psychopharmacology
93. Cardiovascular diseases among patients with schizophrenia
    Muhammad Chanchal Azad, Wendy Diana Shoesmith, Mohammad Al Mamun, Ahmad Faris Abdullah, Daw Khin Saw Naing, Mahadasa Phanindranath, Tanvir Chowdhury Turin · 2015 · Asian Journal of Psychiatry
94. Mortality in schizophrenia
    Pascal Auquier, Christophe Lançon, F. Rouillon, MALCOLM H. LADER · 2007 · Pharmacoepidemiology and Drug Safety
95. Allostatic Load as a Tool for Monitoring Physiological Dysregulations and Comorbidities in Patients with Severe Mental Illnesses
    G. Bízik, M. Picard, Rami Nijjar, V. Tourjman, B. McEwen, S. Lupien, R. Juster · 2013 · Harvard Review of Psychiatry
96. Physical health behaviours and health locus of control in people with schizophrenia-spectrum disorder and bipolar disorder: a cross-sectional comparative study with people with non-psychotic mental illness
    Kurt Buhagiar, Liam Parsonage, David Osborn · 2011 · BMC Psychiatry
97. Voxel-based morphometry in schizophrenia: implications for neurodevelopmental connectivity models, cognition and affect
    Leanne Maree Williams · 2008 · Expert Review of Neurotherapeutics
98. The schizophrenic patient in the somatic hospital
    Povl Munk‐Jørgensen, Ole N Mors, Preben Bo Mortensen, H. Ewald · 2000 · Acta Psychiatrica Scandinavica
99. Keeping Your Patient With Heart Failure Safe
    Celene M Amabile, Anne P. Spencer · 2004 · Archives of Internal Medicine
100. Cardiovascular risks of atypical antipsychotic drug treatment
     Milou‐Daniel Drici, Silvia Giuliana Priori · 2007 · Pharmacoepidemiology and Drug Safety